Clinical Trials

Transcriptomic profiling reveals that suppressing β-catenin in specific mutant cells leads to an overwhelming accumulation of ubiquitinated proteins and cellular stress. This biological response marks a turning point in the treatment of advanced endometrial cancer, which remains a leading cause of

The pharmaceutical industry stands at a crossroads where the sheer volume of data threatens to outpace human cognitive capacity. Approximately 30 percent of mandatory clinical results are not submitted within their required timelines, signaling a significant breakdown in traditional evidence

The traditional paradigm of treating blood cancers with chemotherapy is shifting as genetic engineering allows patients' own white blood cells to be reprogrammed as biological 'GPS' units. In the heart of Malaga, this scientific breakthrough has moved beyond the theoretical realm and into the

The accumulation of p65 protein in the nuclei of macrophages drives a transcriptional change that promotes healing over destructive inflammation. This molecular revelation stands at the heart of a transformative study conducted by researchers at Seoul National University and the Yonsei University

The Joint Steering Committee oversees a research pipeline that allows for the rapid pivot toward new health threats as they emerge in the Southern Hemisphere landscape. This strategic collaboration between Moderna and CSIRO establishes a robust biosecurity framework intended to fortify Australia’s

The resignation of FDA Commissioner Marty Makary on May 12, 2026, effectively unblocked the administrative queue for scheduling critical drug and device advisory meetings. This shift signals a broader effort to revitalize a system that has long been the backbone of regulatory transparency. The